Log in to search using one of your social media accounts:

 

Data Bolster Dual Antithrombotic Therapy in AF PCI Patients Data Bolster Dual Antithrombotic Therapy in AF PCI Patients
A new study supports forgoing traditional triple antithrombotic therapy with aspirin for dual therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation who've undergone PCI.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 20, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

University researchers awarded grant for non-invasive system to detect atrial fibrillation
(Rochester Institute of Technology) A team of engineers and clinicians at Rochester Institute of Technology and the University of Rochester Medical Center received a grant from the National Institutes of Health to develop a non-contact, video recording technology to detect the presence of atrial fibrillation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 20, 2017 Category: International Medicine & Public Health Source Type: news

Afib? There ’s an App for That
While many of us reach for our tablets to scan Facebook, watch the newest series on Netflix, or make a quick purchase on Amazon, researchers want to test their potential for a more serious task: detecting atrial fibrillation (afib). (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - September 18, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Afib? There's an app for that
(University of Rochester Medical Center) While many of us reach for our tablets to scan Facebook or watch Netflix, researchers are testing their potential for a more serious task: detecting atrial fibrillation. They'll enroll up to 300 people to test a technology that uses the camera in tablets to capture changes in heartbeat by measuring subtle variations in skin tone. Their goal: create an inexpensive, easy-to-use app that alerts physicians of the onset of afib, allowing for early treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2017 Category: International Medicine & Public Health Source Type: news

Studies support anti-stroke PFO closure devices from Abbott, Gore
Sykes and Clark; licensee BioMed Central Ltd. A trio of studies published this week in the New England Journal of Medicine showed that devices from Abbott (NYSE:ABT) and W.L. Gore & Assoc. designed to close a heart defect lowered the risk of a recurring episode in certain cryptogenic stroke patients. Long-term results from the 980-patient Respect trial of the Amplatzer device Abbott acquired along with St. Jude Medical this year, along with data from the Reduce study of Gore’s Helex and Cardioform and the French Close study of PFO closure devices with CE Mark approval, showed that they reduced the risk of re...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Surgical Abbott Structural heart W.L. Gore & Associates Source Type: news

Atrial Fibrillation vs. Ventricular Fibrillation
Atrial Fibrillation (AFib) vs. Ventricular Fibrillation (VFib): ECG Differences and Similarities (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 14, 2017 Category: General Medicine Source Type: news

NHS announces new opportunity to prevent thousands of heart attacks and strokes
The NHS has revealed a new drive to save thousands of people from heart attacks and strokes with the support of Public Health England (PHE). The plan comes after the release of a new PHE study suggesting that more than 9,000 heart attacks and up to 14,500 strokes could be prevented within the next three years through better management of high blood pressure, high cholesterol and atrial fibrillation.Hide related content:  Show related contentread more (Source: Management in Practice)
Source: Management in Practice - September 13, 2017 Category: Practice Management Authors: Angela Sharda Tags: *** Editor ' s Pick Patients Latest News Source Type: news

Delayed onset of atrial fibrillation and ventricular tachycardia after an automobile lightning strike - Drigalla D, Essler SE, Stone CK.
BACKGROUND: Lightning strike is a rare medical emergency. The primary cause of death in lightning strike victims is immediate cardiac arrest. The mortality rate from lightning exposure can be as high as 30%, with up to 70% of patients left with significant... (Source: SafetyLit)
Source: SafetyLit - September 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

NHS launches new heart disease prevention drive
Plans to prevent 9,000 heart attacks and 14,000 strokes over three years Related items fromOnMedica Significant drop in heart failure deaths over past year, national audit finds Tenth of men aged 50 have heart age of 60-year-old Stroke can often be avoided, claims study Atrial fibrillation poses greater risk for women than men Never too old to benefit from CVD prevention (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 13, 2017 Category: UK Health Source Type: news

How the Apple Watch Could Change How We Treat Heart Disease
The new Apple Watch Series 3 gives users more real-time information about their heart than ever, and Apple hopes that it will also be able to alert users to potentially concerning heart beat patterns. The current version of the Apple Watch already tracks heart rate. But the newest version comes with cellular built in, which means it can record heart rate continuously anywhere you have service. That could provide valuable, instantly accessible data for detecting when things might be awry with your heart—if it’s racing too fast when you’re at rest, for example. You can also set the monitor to alert you if y...
Source: TIME.com: Top Science and Health Stories - September 12, 2017 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized a fib Apple apple iphone x Apple watch apple watch 3 apple watch heart rate applewatch applewatch heart rate monitor applewatch3 atrial fibrillation continuous heart rate monitor Fitbit Heart Disease heart rate mo Source Type: news

AtriCure launches AtriClip Pro-V in the US
AtriCure (NSDQ:ATRC) said today it launched its AtriClip Pro-V left atrial appendate exclusion system in the US. The newly launched AtriClip Pro-V is designed to be placed through a minimally-invasive surgery and features an open-ended design and tip-first closure mechanism for easier navigation, the Mason, Ohio.-based company claims. “Development of the AtriClip Pro-V is another step in the direction of a comprehensive strategy for management of the left atrial appendage. It expands the options for minimally invasive approaches including right chest access and an easier implantation of an epicardial atrial appe...
Source: Mass Device - September 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiac Implants Cardiovascular Replacement Heart Valves AtriCure Inc. Source Type: news

Apixaban Advantage Before AF Cardioversion Hinted: EMANATE Apixaban Advantage Before AF Cardioversion Hinted: EMANATE
Bolus dosing of apixaban allowed cardioversion in 2 or more hours in patients with mostly recent-onset atrial fibrillation; TEE or other atrial imaging was not always performed.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

7 medtech stories we missed this week: Sept. 8, 2017
[Image from unsplash.com]From BrainScope’s pediatric traumatic brain injury assessment device to EOS Imaging releasing new surgery planning software, here are seven medtech stories we missed this week but thought were still worth a mention. 1. BrainScope to develop pediatric traumatic brain injury assessment device BrainScope announced in a Sept. 7 press release that it will immediately start creating a pediatric capability for its BrainScope One medical neurotechnology. The technology is an FDA-cleared handheld medical device that is designed to assess the full spectrum of traumatic brain injury. The company sa...
Source: Mass Device - September 8, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiac Assist Devices Cardiovascular Clinical Trials Diagnostics Food & Drug Administration (FDA) Imaging mHealth (Mobile Health) Neurological Regulatory/Compliance Research & Development Spinal AliveCor Bonesupport Bra Source Type: news

Is BioSig for Real This Time With Its Pure EP?
A couple years ago, BioSig Technologies, Inc. was poised to apply for FDA clearance to market its technology to improve treatment of atrial fibrillation and ventricular tachycardia. Then its scientific advisors advised the Minneapolis company to put more work into that technology, a hardware-software combination designed to present clearer signals during electrophysiology studies and catheter ablation. The technology, Pure EP, is designed to cut through the background noise of the lab and its equipment during cardiac recordings, enabling physicians to target and neutralize the areas of the heart that are causing atria...
Source: MDDI - September 7, 2017 Category: Medical Devices Authors: Nancy Crotti Tags: MD & M Minneapolis R Software Source Type: news

Should We Refer Symptomatic HF Patients for AF Ablation?
That depends, as suggested by results of the CASTLE-AF study, presented at ESC Congress 2017, in Barcelona, Spain. (Source: ConsultantLive)
Source: ConsultantLive - September 7, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Cardiovascular Diseases Cerebrovascular Diseases Source Type: news

AF Screening Leads the Charge in Cardiology & #039;s Digital Revolution
Diagnosis of atrial fibrillation via handheld iECG monitor looks promising but can we pay for it yet? (Source: ConsultantLive)
Source: ConsultantLive - September 7, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Cardiovascular Diseases Source Type: news

Cardiac Insight raises $5m, looks to raise $5m more
Cardiac Insight said today it raised $4.5 million in a new C-1 round of funding, looking to raise a total of $10 million in the round to support its Cardea Solo 7-day ECG sensor. Funds from the round will support sales, distribution and marketing of the company’s wearable Cardea Solo device, designed to provide both physicians and patients with cardiac data and help diagnose a variety of arrhythmias including atrial fibrillation. “Cardiac Insight has quickly caught the attention of the cardiology community for our game-changing products and revolutionary approach to cardiac care. Our new funding and leader...
Source: Mass Device - September 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Cardiac Insight Source Type: news

New app uses smartphone to measure LVEF
Researchers have developed technology that can use a smartphone camera to measure...Read more on AuntMinnie.comRelated Reading: ACC releases valvular heart imaging guidelines 3D printing helps evaluate leaks after TAVR procedures PROMISE: CCTA better than functional cardiac testing ASE: Echo protocol finds kids' heart abnormalities Echocardiography technique can guide atrial fibrillation ablation (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 7, 2017 Category: Radiology Source Type: news

Kidney Disease Is Linked to Higher Risk for Atrial Fibrillation Kidney Disease Is Linked to Higher Risk for Atrial Fibrillation
Dr Bansal comments on her study examining the link between kidney dysfunction and risk for incident atrial fibrillation beyond"traditional" cardiovascular risk factors.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 6, 2017 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news

One in 10 men aged 50 'have the heart of a 60-year-old'
"One-tenth of 50-year-old men have a heart age 10 years older than they are," BBC News reports. This is the finding of an analysis of 1.2 million people who used the NHS Heart Age Test. The principle behind the test is that you can "age" your heart through unhealthy behaviour such as smoking and being obese. Underlying conditions like high blood pressure and high cholesterol, which often have no noticeable symptoms, can also age the heart. An obese smoker in their 50s who has high blood pressure and high cholesterol could have the heart of a 60- or 70-year-old. The quick and simple test tells you the...
Source: NHS News Feed - September 4, 2017 Category: Consumer Health News Tags: Heart/lungs Source Type: news

CASTLE-AF: Ablation Reduces Mortality in LV Dysfunction, AF CASTLE-AF: Ablation Reduces Mortality in LV Dysfunction, AF
Randomized results suggest that catheter ablation of atrial fibrillation not only provides symptomatic relief but reduces mortality and hospitalization for worsening heart failure vs drug therapy in patients with low ejection fraction.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Web-Savvy Doctor, Patient Education Effort Boost OAC Use in AF Web-Savvy Doctor, Patient Education Effort Boost OAC Use in AF
Use of oral anticoagulants climbed over 1 year in patients with atrial fibrillation in five developing nations randomized, along with their healthcare providers, to an eclectic education intervention.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Web-Savvy Doctor, Patient Education Efforts Boost OAC Use in AF Web-Savvy Doctor, Patient Education Efforts Boost OAC Use in AF
Use of oral anticoagulants climbed over 1 year in patients with atrial fibrillation in five developing nations randomized, along with their healthcare providers, to an eclectic education intervention.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 29, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Ablation of atrial fibrillation improves quality of life more than drugs (CAPTAF)
(European Society of Cardiology) Ablation of atrial fibrillation improves quality of life more than drugs, even though the reduction in atrial fibrillation burden did not differ significantly between treatments, according to late-breaking results from the CAPTAF trial presented today in a Hot Line Session at ESC Congress. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2017 Category: International Medicine & Public Health Source Type: news

Electrocardiogram recording by patients boosts atrial fibrillation diagnosis (REHEARSE-AF)
(European Society of Cardiology) Electrocardiogram (ECG) recording by patients with remote analysis by professionals identifies more atrial fibrillation (AF) than routine care, according to late-breaking results from a randomised trial presented today in a Hot Line -- LBCT Session at ESC Congress1 and published in Circulation. The approach has the potential to reduce AF-related strokes by starting preventative treatment earlier. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2017 Category: International Medicine & Public Health Source Type: news

ESC 2017 Roundup: Biotronik touts lowered mortality for AF patients treated with cath ablation
Biotronik today released results from the Castle-AF study exploring the use of catheter ablation to treat heart failure patients with atrial fibrillation, touting a 38% composite reduction in all-cause mortality and hospitalization for worsening heart failure. The 398-patient, 33-site study compared the results of catheter ablation treatment for AF in heart failure patients using implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators to standard-of-care pharmacological therapy, the company said. Biotronik touted it as the largest study of its kind to date. Results indicated a 47% r...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Clinical Trials Biotronik Medtronic Source Type: news

Broad AF Risk-Factor Intervention Preserves Sinus Rhythm: RACE-3 Broad AF Risk-Factor Intervention Preserves Sinus Rhythm: RACE-3
Aggressive meds, exercise, dietary restrictions, and counseling, started early after atrial-fibrillation onset, kept recurrences at bay for up to a year in a small randomized trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 28, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Atrial fibrillation and blood pressure: More than just a number (AFFIRM)
(European Society of Cardiology) New research presented at ESC Congress today shows, for the first time, that blood pressure control is pivotal in reducing major bleeding and stroke risk in patients with atrial fibrillation (AF). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2017 Category: International Medicine & Public Health Source Type: news

Apixaban lowers stroke risk in AF patients undergoing cardioversion (EMANATE)
(European Society of Cardiology) Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-na ï ve patients with atrial fibrillation scheduled for elective cardioversion, according to late-breaking results from the EMANATE trial presented today in a Hot Line LBCT Session at ESC Congress. Rates of bleeding were similar between the two groups. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2017 Category: International Medicine & Public Health Source Type: news

Education and feedback improve use of stroke prevention drugs in AF (IMPACT-AF)
(European Society of Cardiology) Education of healthcare providers and patients with atrial fibrillation has led to a 9 percent absolute increase in the use of anticoagulation therapies to reduce stroke, according to late-breaking results from the IMPACT-AF trial presented today in a Hot Line LBCT Session at ESC Congress1 and published in the Lancet. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2017 Category: International Medicine & Public Health Source Type: news

Catheter ablation better than traditional drug therapies for treating atrial fibrillation
(University of Utah Health) New study shows radiofrequency catheter ablation lowered hospitalization and mortality rates by 47 and 44 percent respectively in patients with atrial fibrillation (AF), a contributing factor to heart failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2017 Category: International Medicine & Public Health Source Type: news

When two is better than three: Dual antithrombotic therapy cuts bleeding risk
(Brigham and Women's Hospital) Clinical trial finds that dabigatran dual therapy after stenting reduced bleeding risk for patients with atrial fibrillation compared with standard triple therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2017 Category: International Medicine & Public Health Source Type: news

Undiagnosed Heart Condition'AFib' May Be Common, Study Suggests
Continuous long-term monitoring led to diagnosis in 1 out of 3 high-risk adults Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Pacemakers and Implantable Defibrillators (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 26, 2017 Category: Consumer Health News Source Type: news

Undiagnosed Heart Condition'AFib' May Be Common, Study Suggests
SATURDAY, Aug. 26, 2017 -- Many people at risk for atrial fibrillation probably do have the irregular heart rhythm but have not been diagnosed, a new study reports. Nearly 1 out of 3 patients in the study had undetected atrial fibrillation that was... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 26, 2017 Category: General Medicine Source Type: news

Implanted cardiac monitors indicate incidence of undiagnosed AFib may be substantial in high-risk patients
(The JAMA Network Journals) With the use of implanted cardiac monitors researchers found a substantial incidence (nearly 30 percent) of previously undiagnosed atrial fibrillation (AF) after 18 months in patients at high risk of both AF and stroke, according to a study published by JAMA Cardiology. The study is being released to coincide with its presentation at the European Society of Cardiology Congress 2017. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 26, 2017 Category: International Medicine & Public Health Source Type: news

Type 1 Diabetes Found to Raise Atrial Fibrillation Risk Type 1 Diabetes Found to Raise Atrial Fibrillation Risk
Women with type 1 diabetes appear particularly vulnerable to atrial fibrillation, with higher HbA1c levels and renal complications further raising the risk.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 25, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Cardiome Provides U.S. Regulatory Update For BRINAVESS
VANCOUVER, Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME/ TSX:COM) today announced that it has received a response from the U.S. Food and Drug Administration (FDA) regarding the regulatory path for BRINAVESS... Biopharmaceuticals, Cardiology, FDA Cardiome Pharma, BRINAVESS, vernakalant, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 21, 2017 Category: Pharmaceuticals Source Type: news

How Serious Is Atrial Fibrillation?
Title: How Serious Is Atrial Fibrillation?Category: Doctor's& Expert's views on SymptomsCreated: 8/14/2017 12:00:00 AMLast Editorial Review: 8/14/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - August 14, 2017 Category: Cardiology Source Type: news

Kidney Disease May Boost Risk of Abnormal Heartbeat
And, the worse the kidney problems, the greater the odds of the heart condition, researchers say Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Kidney Diseases (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 11, 2017 Category: Consumer Health News Source Type: news

Kidney Disease May Boost Risk of Abnormal Heartbeat
THURSDAY, Aug. 10, 2017 -- People with failing kidneys are at increased risk of developing a life-threatening abnormal heart rhythm, a new report suggests. Chronic kidney disease can as much as double a patient's risk of atrial fibrillation, a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 10, 2017 Category: General Medicine Source Type: news

Working long hours increases the risk of heart disease and mental health problems
Research published by theEuropean Heart Journal shows that working 55 hours or more per week increases your risk of developing atrial fibrillation and stroke. However, other medical problems such as obesity and diabetes are also linked with working longer hours so the causation is not yet known.The Guardian (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 8, 2017 Category: Endocrinology Source Type: news

Could AF Ablation have a & quot;Placebo & quot; Effect?
A small study raises big questions about patients'perceptions of AF symptoms after pulmonary vein ablation. What do you think? (Source: ConsultantLive)
Source: ConsultantLive - August 7, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Cardiovascular Diseases Source Type: news

Subclinical Atrial Fibrillation Rears its Head, Again
Increased detection of subclinical atrial fibrillation intensifies a common clinical quandary in AF patients: to anticoagulate, or not? (Source: ConsultantLive)
Source: ConsultantLive - August 7, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Cardiovascular Diseases Source Type: news

FDA Drug Safety Communication: Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events
[12-19-2011] The U.S. Food and Drug Administration (FDA) has completed a safety review of the heart drug Multaq (dronedarone). This review showed that Multaq increased the risk of serious cardiovascular events, including death, when used by patients in permanent atrial fibrillation (AF). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 3, 2017 Category: Drugs & Pharmacology Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 1, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Integer Holdings: What you need to know Greatbatch and Lake Region Medical merged nearly two years ago to become Integer Holdings Co., a giant medical device contract manufacturer that could theoretically do almost anything for...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Medtronic touts reduced costs, rehospitalizations in cryoballoon vs RF AF ablation trial analysis
Medtronic (NYSE:MDT) today released data from a health economic analysis from the Fire And Ice trial comparing its Arctic Front cryoballoon catheter to its ThermoCool radiofrequency ablation cath, touting that cryoballoon treatment could reduce costs and rehospitalizations when used to treat paroxysmal atrial fibrillation. Economic analysis results from the trial were published today in the Journal of the American Heart Association. Researchers analyzed data from the 769-patient trial, which Medtronic claims is the largest to compare cryoballoon ablation to point-by-point RF ablation for treating paroxysmal AF, o...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Catheters Clinical Trials Medtronic Source Type: news

Japan clears CardioFocus ’ HeartLight
CardioFocus said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its HeartLight endoscopic ablation system with an indication for treating paroxysmal atrial fibrillation. The Marlborough, Mass.-based company’s HeartLight system is designed to allow electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with a high procedural flexibility. The device includes a compliant balloon to accommodate diverse PV anatomies and has a short learning curve to allow for quick adoption of the tech, the company said. To support the...
Source: Mass Device - July 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Regulatory/Compliance CardioFocus Inc. newtag Source Type: news

Stroke warning: Reduce your risk by eating this sweet treat
STROKE can be a complication of suffering from atrial fibrillation - a type of irregular heartbeat. However, eating chocolate can reduce your risk of the latter heart condition, according to a new study. (Source: Daily Express - Health)
Source: Daily Express - Health - July 31, 2017 Category: Consumer Health News Source Type: news

CardioFocus(R) Receives Approval For HeartLight(R) Endoscopic Ablation System From The Japanese Ministry Of Health, Labour And Welfare
MARLBOROUGH, Mass., July 31, 2017 -- (Healthcare Sales & Marketing Network) -- CardioFocus, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the HeartLight Endoscopic Ablation System for the treatment of paroxysma... Devices, Cardiology, Regulatory CardioFocus, HeartLight, Endoscopic Ablation, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 31, 2017 Category: Pharmaceuticals Source Type: news

Winners of the Qualcomm Tricorder XPRIZE for Medical Laboratory Testing Were Announced in April, Five Years After the Competition Began
More than 312 teams applied for the completion and the prize-winning hand-held device uses clinical laboratory assays to diagnose up to 34 different medical conditions Star Trek fans among clinical laboratory manager and pathologist will be excited to learn that the winners of the Qualcomm Tricorder XPRIZE were announced earlier this year, five years after […] (Source: Dark Daily)
Source: Dark Daily - July 24, 2017 Category: Laboratory Medicine Authors: jude Tags: Laboratory Pathology anemia atrial fibrillation Basil Harris Basil Leaf Technologies cholesterol Chronic Obstructive Pulmonary Disease Chung-Kang Peng clinical laboratory Dark Daily dark intelligence group Dark Report Diabetes Mell Source Type: news